Dr. Rebecca Redman, MD
Claim this profileJames Graham Brown Cancer Center
Studies Cancer
Studies Squamous Cell Carcinoma
15 reported clinical trials
28 drugs studied
Area of expertise
1Cancer
p16 positive
Stage IV
p16 negative
2Squamous Cell Carcinoma
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Rebecca Redman, MD is currently running
MT-6402
for Solid Cancers
This will be a Phase 1 Open-label, dose escalation and expansion study of MT-6402 (an Engineered Toxin Body (ETB)) in subjects with advanced solid cancer that expresses PD-L1
Recruiting1 award Phase 110 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about Rebecca Redman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Rebecca Redman, MD has experience with
- Pembrolizumab
- Nivolumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- PFK-158
- Folfirinox
Breakdown of trials Rebecca Redman, MD has run
Cancer
Squamous Cell Carcinoma
Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca Redman, MD specialize in?
Rebecca Redman, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved p16 positive patients, or patients who are Stage IV.
Is Rebecca Redman, MD currently recruiting for clinical trials?
Yes, Rebecca Redman, MD is currently recruiting for 8 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Rebecca Redman, MD has studied deeply?
Yes, Rebecca Redman, MD has studied treatments such as Pembrolizumab, Nivolumab, Cisplatin.
What is the best way to schedule an appointment with Rebecca Redman, MD?
Apply for one of the trials that Rebecca Redman, MD is conducting.
What is the office address of Rebecca Redman, MD?
The office of Rebecca Redman, MD is located at: James Graham Brown Cancer Center, Louisville, Kentucky 40202 United States. This is the address for their practice at the James Graham Brown Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.